This column provides an overview of how institutional biosafety committees enhance and promote clinical research and scientific discovery.
This column explores the distinctions between registries and natural history studies, highlighting the potential value of each in informing and shaping clinical development in rare diseases.
This column highlights how incorporating data from patient disease registries in a real-world data mix offers four impactful benefits for clinical researchers.
Dispatches collected from sources in the world beyond ACRP (no endorsements implied) and edited for your reading pleasure on diversity, equity, and inclusion in healthcare and research.
This article illustrates the wide-ranging impact of COVID-19 on research processes and associated best practices that have emerged to manage these impacts on the research environment at The Ohio State University Medical Center.